141 related articles for article (PubMed ID: 24742710)
21. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells.
Maxwell IH; Glode LM; Maxwell F
Cancer Res; 1991 Aug; 51(16):4299-304. PubMed ID: 1868451
[TBL] [Abstract][Full Text] [Related]
22. Complex formation by the human RAD51C and XRCC3 recombination repair proteins.
Masson JY; Stasiak AZ; Stasiak A; Benson FE; West SC
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8440-6. PubMed ID: 11459987
[TBL] [Abstract][Full Text] [Related]
23. Estrogen induces RAD51C expression and localization to sites of DNA damage.
Alayev A; Salamon RS; Manna S; Schwartz NS; Berman AY; Holz MK
Cell Cycle; 2016 Dec; 15(23):3230-3239. PubMed ID: 27753535
[TBL] [Abstract][Full Text] [Related]
24. The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C.
Gruver AM; Miller KA; Rajesh C; Smiraldo PG; Kaliyaperumal S; Balder R; Stiles KM; Albala JS; Pittman DL
Mutagenesis; 2005 Nov; 20(6):433-40. PubMed ID: 16236763
[TBL] [Abstract][Full Text] [Related]
25. Targeting diphtheria toxin A-chain transcription to activated endothelial cells using an E-selectin promoter.
Maxwell IH; Kaletta C; Naujoks K; Maxwell F
Angiogenesis; 2003; 6(1):31-8. PubMed ID: 14517402
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization and identification of mouse Rad51d splice variants.
Gruver AM; Yard BD; McInnes C; Rajesh C; Pittman DL
BMC Mol Biol; 2009 Mar; 10():27. PubMed ID: 19327148
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast Cancer.
Shi Y; Shen M; Xu M; Tao M; Chen K; Zhu Q
Int J Gen Med; 2022; 15():4925-4936. PubMed ID: 35601003
[TBL] [Abstract][Full Text] [Related]
28. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib.
Min A; Im SA; Yoon YK; Song SH; Nam HJ; Hur HS; Kim HP; Lee KH; Han SW; Oh DY; Kim TY; O'Connor MJ; Kim WH; Bang YJ
Mol Cancer Ther; 2013 Jun; 12(6):865-77. PubMed ID: 23512992
[TBL] [Abstract][Full Text] [Related]
29. Synthetic dual-input mammalian genetic circuits enable tunable and stringent transcription control by chemical and light.
Chen X; Li T; Wang X; Du Z; Liu R; Yang Y
Nucleic Acids Res; 2016 Apr; 44(6):2677-90. PubMed ID: 26673714
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemia.
Sellick G; Fielding S; Qureshi M; Catovsky D; ; Houlston R
Leuk Lymphoma; 2008 Jan; 49(1):130-3. PubMed ID: 18203022
[TBL] [Abstract][Full Text] [Related]
31. Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
Wiese C; Hinz JM; Tebbs RS; Nham PB; Urbin SS; Collins DW; Thompson LH; Schild D
Nucleic Acids Res; 2006; 34(9):2833-43. PubMed ID: 16717288
[TBL] [Abstract][Full Text] [Related]
32. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
[TBL] [Abstract][Full Text] [Related]
33. Domain mapping of the Rad51 paralog protein complexes.
Miller KA; Sawicka D; Barsky D; Albala JS
Nucleic Acids Res; 2004; 32(1):169-78. PubMed ID: 14704354
[TBL] [Abstract][Full Text] [Related]
34. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
Somyajit K; Mishra A; Jameei A; Nagaraju G
Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
[TBL] [Abstract][Full Text] [Related]
35. DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination.
Wei L; Nakajima S; Böhm S; Bernstein KA; Shen Z; Tsang M; Levine AS; Lan L
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3495-504. PubMed ID: 26100862
[TBL] [Abstract][Full Text] [Related]
36. The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy.
Rodrigue A; Coulombe Y; Jacquet K; Gagné JP; Roques C; Gobeil S; Poirier G; Masson JY
J Cell Sci; 2013 Jan; 126(Pt 1):348-59. PubMed ID: 23108668
[TBL] [Abstract][Full Text] [Related]
37. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
38. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.
Amit D; Hochberg A
J Transl Med; 2010 Dec; 8():134. PubMed ID: 21162716
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes.
Dosanjh MK; Collins DW; Fan W; Lennon GG; Albala JS; Shen Z; Schild D
Nucleic Acids Res; 1998 Mar; 26(5):1179-84. PubMed ID: 9469824
[TBL] [Abstract][Full Text] [Related]
40. Rice RAD51 paralogs play essential roles in somatic homologous recombination for DNA repair.
Xu Z; Zhang J; Xu M; Ji W; Yu M; Tao Y; Gong Z; Gu M; Yu H
Plant J; 2018 Jul; 95(2):282-295. PubMed ID: 29729110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
